Newly licensed drugs - Should be on probation until their value is demonstrated

被引:33
作者
Ferner, RE
机构
关键词
D O I
10.1136/bmj.313.7066.1157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1157 / 1158
页数:2
相关论文
共 11 条
[1]  
*COMM DEP HUM SERV, 1995, GUID PHARM IND PREP
[2]  
Davey PG, 1996, BRIT MED J, V312, P613, DOI 10.1136/bmj.312.7031.613
[3]   PROBABILITY OF ADVERSE EVENTS THAT HAVE NOT YET OCCURRED - A STATISTICAL REMINDER [J].
EYPASCH, E ;
LEFERING, R ;
KUM, CK ;
TROIDL, H .
BRITISH MEDICAL JOURNAL, 1995, 311 (7005) :619-620
[4]   New antiepileptic drugs: A systematic review of their efficacy and tolerability [J].
Marson, AG ;
Kadir, ZA ;
Chadwick, DW .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 313 (7066) :1169-1174
[5]  
MINGOT G, 1996, BRIT MED J, V313, P1158
[6]   HEALTH-CARE - WHATS SCIENCE GOT TO DO WITH IT [J].
PECKHAM, M ;
SMITH, R .
BRITISH MEDICAL JOURNAL, 1995, 310 (6974) :208-208
[7]   Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: Life table method applied to health authority population [J].
Pharoah, PDP ;
Hollingworth, W .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 312 (7044) :1443-1448
[8]  
RAWLINS MD, 1995, J ROY COLL PHYS LOND, V29, P41
[9]   PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].
SHEPHERD, J ;
COBBE, SM ;
FORD, I ;
ISLES, CG ;
LORIMER, AR ;
MACFARLANE, PW ;
MCKILLOP, JH ;
PACKARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307
[10]  
The IFNb Multiple Sclerosis Study Group, 1993, NEUROLOGY, V43, P655